BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25864220)

  • 1. IFNL3 polymorphisms and HCV infection in patients with beta thalassemia.
    Origa R; Marceddu G; Danjou F; Perseu L; Satta S; Demartis FR; Piga A; Longo F; Lai ME; Vacquer S; Galanello R
    Ann Hepatol; 2015; 14(3):389-95. PubMed ID: 25864220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.
    O'Brien TR; Pfeiffer RM; Paquin A; Lang Kuhs KA; Chen S; Bonkovsky HL; Edlin BR; Howell CD; Kirk GD; Kuniholm MH; Morgan TR; Strickler HD; Thomas DL; Prokunina-Olsson L
    J Hepatol; 2015 Nov; 63(5):1103-10. PubMed ID: 26186989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of
    Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
    World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection.
    Di Marco V; Bronte F; Calvaruso V; Capra M; Borsellino Z; Maggio A; Renda MC; Pitrolo L; Lo Pinto MC; Rizzo M; Fiorenza F; Gerardi C; Grimaudo S; Di Cristina A; Levrero M; Craxì A
    Haematologica; 2012 May; 97(5):679-86. PubMed ID: 22180419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection.
    Chang KC; Tseng PL; Wu YY; Hung HC; Huang CM; Lu SN; Wang JH; Lee CM; Chen CH; Tsai MC; Yen YH; Lin MT; Wu CK; Huang CC; Chen HH; Hu TH
    Clin Gastroenterol Hepatol; 2015 May; 13(5):1017-24. PubMed ID: 25460552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of IFNL3.rs12979860 and IFNL4.ss469415590 polymorphism on clearance of hepatitis C virus infection among Egyptians.
    Knapp S; Zakaria Z; Hashem M; Zaghla H; Khakoo SI; Waked I; Thursz M; Abdelwahab SF
    Hepatol Int; 2015 Apr; 9(2):251-7. PubMed ID: 25788203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of interferon lambda polymorphisms with elevated baseline viral loads in chronic hepatitis C virus genotype 6 infection.
    Nguyen LT; Van Nguyen D; Carr MJ; Hall WW; Nguyen LA
    Arch Virol; 2018 Jan; 163(1):115-124. PubMed ID: 29022122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism rs368234815 of interferon lambda 4 gene and spontaneous clearance of hepatitis C virus in haemodialysis patients: a case-control study.
    Grzegorzewska AE; Mostowska A; Świderska MK; Marcinkowski W; Stolarek I; Figlerowicz M; Jagodziński PP
    BMC Infect Dis; 2021 Jan; 21(1):102. PubMed ID: 33482747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum IFN-λ3 Levels Correlate with Serum Hepatitis C Virus RNA Levels in Symptomatic Patients with Acute Hepatitis C.
    Imoto S; Kim SR; Amano K; Iio E; Yoon S; Hirohata S; Yano Y; Ishikawa T; Katsushima S; Komeda T; Fukunaga T; Chung H; Kokuryu H; Horie Y; Hatae T; Fujinami A; Kim SK; Kudo M; Tanaka Y
    Dig Dis; 2017; 35(6):531-540. PubMed ID: 29040985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection.
    Eslam M; Leung R; Romero-Gomez M; Mangia A; Irving WL; Sheridan D; Spengler U; Mollison L; Cheng W; Bugianesi E; McLeod D; Zaitoun AM; Attino V; Goeltz D; Nattermann J; Douglas M; Booth DR; George J; Ahlenstiel G
    J Hepatol; 2014 Aug; 61(2):235-41. PubMed ID: 24768758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult hepatitis C virus infection in hemophilia patients and its correlation with interferon lambda 3 and 4 polymorphisms.
    Nafari AH; Ayadi A; Noormohamadi Z; Sakhaee F; Vaziri F; Siadat SD; Fateh A
    Infect Genet Evol; 2020 Apr; 79():104144. PubMed ID: 31838260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFNL4 and IFNL3 associated polymorphisms strongly influence the spontaneous IFN-alpha receptor-1 expression in HCV-infected patients.
    Bordi L; Caglioti C; Garbuglia AR; Lapa D; Castilletti C; Taibi C; Capobianchi MR; Lalle E
    PLoS One; 2015; 10(2):e0117397. PubMed ID: 25675103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of ICAM 1 and IL28 as predictors of liver fibrosis severity and viral clearance in hepatitis C genotype 4.
    Rizk NM; Derbala MF
    Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):262-8. PubMed ID: 23137758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of IL28B rs12979860, rs11881222 and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients.
    Derbala M; Rizk NM; Al-Kaabi S; John A; Sharma M; El-dweik N; Yakoob R; Pasic F; Almohanadi M; Alejji K; Abdelmola A; Butt M
    Virology; 2013 Sep; 444(1-2):292-300. PubMed ID: 23866096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 28B.rs12979860 genotype does not affect hepatitis C viral load in Egyptians with genotype 4 chronic infection.
    Abdelwahab SF; Zakaria Z; Allam WR; Hamdy S; Mahmoud MA; Sobhy M; Rewisha E; Waked I
    Arch Virol; 2015 Nov; 160(11):2833-7. PubMed ID: 26280523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon λ3 gene (IL28B) is associated with spontaneous or treatment-induced viral clearance in hepatitis C virus-infected multitransfused patients with thalassemia.
    Biswas A; Firdaus R; Gupta D; Ghosh M; Saha K; Chowdhury P; Bhattacharyya M; Sadhukhan PC
    Transfusion; 2017 Jun; 57(6):1376-1384. PubMed ID: 28419488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFNL3 (IL28B) and IFNL4 polymorphisms are associated with treatment response in Thai patients infected with HCV genotype 1, but not with genotypes 3 and 6.
    Akkarathamrongsin S; Thong VD; Payungporn S; Poovorawan K; Prapunwattana P; Poovorawan Y; Tangkijvanich P
    J Med Virol; 2014 Sep; 86(9):1482-90. PubMed ID: 24782280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favourable IFNL3 genotypes are associated with spontaneous clearance and are differentially distributed in Aboriginals in Canadian HIV-hepatitis C co-infected individuals.
    Moqueet N; Infante-Rivard C; Platt RW; Young J; Cooper C; Hull M; Walmsley S; Klein MB;
    Int J Mol Sci; 2015 Mar; 16(3):6496-512. PubMed ID: 25803108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection.
    Rao HY; Sun DG; Jiang D; Yang RF; Guo F; Wang JH; Liu F; Zhang HY; Zhang HH; Du SC; Jin Q; Qin H; Lok AS; Wei L
    J Viral Hepat; 2012 Mar; 19(3):173-81. PubMed ID: 22329371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?
    Di Marco V; D'Ambrosio R; Bronte F; Saracco G; Lanza AG; Forni G; Poggiali E; Calvaruso V;
    Dig Liver Dis; 2016 Jun; 48(6):650-5. PubMed ID: 27012446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.